Earnings Summary – Birkenstock Reports First Quarter 2026 Revenue Growth of 11%
Birkenstock Holding plc, (NYSE: BIRK) a global brand that manufactures footwear products designed to encourage proper foot health and biomechanics....
ADVERTISEMENT
Healthcare
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7%
West Pharmaceutical Services, Inc. (NYSE: WST) reported fourth-quarter 2025 financial results on Thursday that exceeded analyst expectations, supported by strong...
Avantor reports Q4 sales decline as “Revival” turnaround begins
Avantor, Inc. (NYSE: AVTR) on Wednesday reported a decline in fourth-quarter revenue and provided a cautious outlook for 2026, as...
Tenet Healthcare shares steady after strong Q4, upbeat 2026 outlook
Tenet Healthcare Corp. (NYSE: THC) shares were trading around $192 to $195 in midday trade after the company reported fourth-quarter...
Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues
Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, has reported a decline in adjusted earnings for the fourth quarter...
Key highlights from Humana’s (HUM) Q4 2025 earnings results
Humana Inc. (NYSE: HUM) reported its fourth quarter 2025 earnings results today. Total revenues were $32.5 billion compared to $29.2...
Quest Diagnostics Shares Jump on Q4 Beat; FY25 Revenue Rises, 2026 Outlook Raised
Shares, 52-Week Range, Recent Trend Quest Diagnostics Inc. (NYSE: DGX) shares rose sharply following its Q4 and FY 2025...
Medpace Q4 Earnings Beat Overshadowed by Cancellation Spike
Medpace Holdings, Inc. (NASDAQ: MEDP) delivered a strong fourth quarter with significant top-line and bottom-line growth, beating analyst estimates. However,...
InMode shares move after fourth-quarter revenue growth and full-year decline
InMode Ltd (NASDAQ: INMD) reported its financial results for the fourth quarter and full year ended December 31, 2025, showing...
Zimmer Biomet shares climb after fourth-quarter sales and earnings growth
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) closed at $93.60, up 4.3% on the day, after reporting fourth-quarter and full-year 2025...